News

As per the terms of the agreement, IntelGenx has obtained worldwide rights to US Patent 7,592,328 and all corresponding foreign patents and patent applications to exclusively develop and

In the study, 25 asymptomatic HAE patients with a history of frequent attacks received once weekly administrations of 50 U/kg of Ruconest for 8 weeks. The study results

Pfizer and Protalix BioTherapeutics had entered into an agreement to develop and commercialise Taliglucerase alfa On 30 November 2009. Under the terms of the agreement, Pfizer received exclusive

Under the contract, Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead‘s liver disease research programmes. Gilead Research senior vice president William

Simcor is indicated to reduce elevated total-C, LDL-C, Apo B, non-HDL-C, TG, or to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia when treatment with simvastatin

Cognistar is a nutriment for the brain which regulates and improves nerve cell metabolism, promotes synapse generation, induces nerve cell differentiation, and protects nerve cells against damages by

The tribunal awarded Basilea $130m, including lost milestones, other damages and interest. Ceftobiprole is an anti-MRSA broad-spectrum cephalosporin antibiotic exhibiting activity against a wide spectrum of Gram-positive bacteria,

Under this alliance, GSK will supply bulk vaccine and provide technology and expertise to enable Binnopharm to undertake the secondary manufacture, including filling and packaging of a number

Veeva Systems is a SaaS-based CRM solutions for the global life sciences industry. Veeva Systems president and CEO Peter Gassner said that they are excited to enter into